Karolinska Institutet in Stockholm and AstraZeneca have formed a three-year collaborative research agreement that will apply molecular imaging technologies to generate new diagnostic imaging tools.

Molecular Imaging, a contract research organization (CRO) providing multi-modality preclinical in vivo imaging services to pharmaceutical and biotechnology companies, has entered into a licensing agreement with Dana-Farber Cancer Institute in Boston to access a number of luciferase-enabled cancer cell lines developed at Dana-Farber.

Clarient, a GE Healthcare company, and Acorn Research have formed a collaboration around molecular testing of tumor samples.

PETNET Solutions, a wholly owned subsidiary of Siemens Medical Solutions USA, has entered into a commercial agreement with Eli Lilly that grants Siemens PETNET the right to manufacture and distribute Lilly’s molecular imaging agent that is currently under review by the FDA for PET imaging.

Integrated Oncology Network has entered into an exclusive alliance agreement with Philips Electronics North America to participate with the Philips Cancer Center Group.

Agilent Technologies and the University of Technology, Sydney in Australia have established a joint nuclear MR research facility.

GE Healthcare has formed a manufacturing agreement with Advanced Accelerator Applications, a pharmaceutical company based in Milan, Italy, and focused on molecular nuclear medicine.

Agfa HealthCare is changing the name of Insight Agents to Agfa HealthCare Imaging Agents.

Dilon Diagnostics, a developer of molecular breast imaging technologies, has become the exclusive U.S. distributor of products from SurgicEye, developer of intraoperative soft tissue imaging and navigation technologies.

GE Hitachi Nuclear Energy (GEH) and Exelon are partnering to study the feasibility of producing molybdenum-99 (Mo-99), the most commonly used medical isotope, at Clinton Power Station, a nuclear power plant in Clinton, Ill.

LI-COR Biosciences has entered into a licensing agreement with Johns Hopkins University in Baltimore for compounds and imaging methods targeting prostate-specific membrane antigen (PSMA) developed in the laboratory of Martin G. Pomper, MD, a neuroradiologist at Johns Hopkins.

Caliper Life Sciences of Hopkinton, Mass., has launched a collaboration with the Center for Genome Analysis at Yale University in New Haven, Conn.

Dilon Diagnostics has formed a sales alliance with PenRad, in which Dilon is expanding its portfolio to include the PenRad Mammography Information System (MIS), and Volpara, a quantitative breast density assessment tool that converts the qualitative breast x-ray image into quantitative data.

Advanced Medical Isotope Corporation (AMIC), a developer and distributor of medical isotopes, has entered into a strategic relationship with Spivak Management and Mann Healthcare Partners to form a joint venture to develop and execute AMIC's business strategy.

Concord Medical Services and GE Healthcare have signed a memorandum of understating (MOU) to form a preferred strategic partnership in China.

National Imaging Associates (NIA) and the American College of Radiation Oncology (ACRO) have signed a collaborative agreement to establish guidelines in radiation therapy treatment.

The University of California (UC), San Diego Health Sciences has joined other U.S. life science research institutions as part of Pfizer's Centers for Therapeutic Innovation.

Michigan State University (MSU) will work with Cardinal Health to open a new radio-pharmacy on campus, allowing access to nuclear imaging agents created at MSU’s medical cyclotron, according to a press release from MSU.

Agfa HealthCare has teamed up with TeraRecon to combine the unified image and information management workflow of Agfa HealthCare's Impax 6 PACS with the advanced image processing of TeraRecon's iNtuition technology.

Biotech company ImaginAb has locked a research deal with GE Healthcare to develop PET diagnostic imaging agents for cardiovascular disease, the companies said on June 5.